Free Newsletter
Businessman donates $100M to HIV vaccine institute
Massachusetts businessman Phillip T. Ragon announced today that he is donating $100 million to create a new research institute that will be devoted to discovering an effective AIDS vaccine. Ragon is contributing $10 million a year for 10 years to fund work that will draw together top scientists from Harvard, MIT and Mass. General.
The Boston Globe reports that the institute being set up with Ragon's money will be modeled on the Broad Institute of Cambridge, which is renowned for creating collaborations among leading scientists. The gift frees the researchers from having to scramble for federal funds, which have been tight.
"You might say back in Newton's time, you could be a solo physicist conducting research," Ragon told the Globe. "But today, you need projects where large groups of people come together to focus on advancing the state of science."
- read the report from the Boston Globe
Related Articles:
AIDS group offers $150,000 vax research challenge
Fauci says HIV vaccine requires a new approach
World AIDS day marked by new vaccine progress
T-cell HIV vax still promising
Nobel winners frustrated, hopeful about AIDS vax
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: